Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 1 1

Status

Recruiting 16Active not recruiting 16Completed 4Not yet recruiting 3Withdrawn 2

Sponsor Class

OTHER 2NIH 1INDUSTRY 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 3Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neoplasm Metastasis 1

Interventions

pembrolizumab 66Cyclophosphamide 44Cisplatin 43Nivolumab 36Paclitaxel 32Carboplatin 31Radiotherapy 29Gemcitabine 28Docetaxel 25Dexamethasone 22atezolizumab 21Doxorubicin 19Bevacizumab 19Magnetic Resonance Spectroscopy 17fludarabine 16Vincristine 16Lenalidomide 16Etoposide 16Radiosurgery 15Letrozole 15Ipilimumab 15Fluorouracil 15Blood Specimen Collection 15palbociclib 14Rituximab 14Radiation 14Leucovorin 14Cytarabine 14Surveys and Questionnaires 13Specimen Handling 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Androgen Antagonists × 90 days × Clear all
NCT03388619 2026-05-27

Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
30 enrolled 16 charts
Genitourinary

Prostatic Neoplasms

NCT03644303 2026-05-14

TRAP

Royal Marsden NHS Foundation Trust

Phase NA Completed
86 enrolled 27 charts
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT04191096 2026-04-29

KEYNOTE-991

Merck Sharp & Dohme LLC

Phase 3 Completed
1,251 enrolled 15 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body

NCT07428642 2026-03-18

PSMA PET/CT-Based Multimodal Model for Predicting Response to First-Line Therapy in mHSPC.

First Affiliated Hospital of Wenzhou Medical University

Completed
168 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡